Balloon Expandable Transcatheter Aortic Valve Implantation Without Predilation of the Aortic Valve
Launched by INSTITUT FÜR PHARMAKOLOGIE UND PRÄVENTIVE MEDIZIN · Apr 29, 2014
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Prior to the deployment of transcatheter heart valves (THV), balloon aortic valvuloplasty (BAV) is usually performed under rapid right ventricular pacing (burst \>180 bpm) with the induction of a functional cardiac arrest for up to 30 seconds. Aortic valve predilation is aiming at facilitating the crossing of the aortic annulus, accurate valve positioning and does also provide information on the anatomy of the valve complex. However, BAV has been shown to have a number of potentially detrimental effects, such as:
* Functional cardiac arrest induced by rapid pacing leads to transient corona...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with an indication for TAVI as to the Edwards THV IFU
- • Eligible for TABI with AND without BAV
- • Signed informed consent
- Exclusion Criteria:
- • Logistic EuroSCORE I \>50%
- • Mitral or tricuspid valvular insufficiency (\> grade II)
- • Previous aortic valve replacement
- • Uncontrolled atrial fibrillation
- • Left ventricular or atrial thrombus by echocardiography
- • Recent cerebrovascular event (within the last 3 months)
- • High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
Trial Officials
Holger Schröfel, MD
Principal Investigator
Clinic for Cardiac Surgery Karlsruhe
Justus Strauch, Prof.
Principal Investigator
Klinik für Herz- und Thoraxchirurgie
About Institut Für Pharmakologie Und Präventive Medizin
The Institut für Pharmakologie und Präventive Medizin is a leading research institution dedicated to advancing the fields of pharmacology and preventive medicine. With a strong focus on innovative clinical trials, the institute aims to develop and evaluate novel therapeutic strategies to improve patient outcomes and enhance public health. By fostering collaboration among multidisciplinary teams of researchers, clinicians, and industry partners, the institute is committed to translating scientific discoveries into practical applications that address unmet medical needs. Its rigorous research framework and commitment to ethical standards ensure the integrity and reliability of its clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Augsburg, , Germany
Karlsruhe, Baden Württemberg, Germany
Bochum, Nordrhein Westfalen, Germany
Bad Neustadt An Der Saale, , Germany
Bad Rothenfelde, , Germany
Essen, , Germany
Köln, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials